NEW YORK ( TheStreet) -- Haemonetics Corporation (NYSE: HAE) hit a new 52-week high Wednesday as it is currently trading at $67.44, above its previous 52-week high of $67.42 with 11,901 shares traded as of 10:21 a.m. ET. Average volume has been 141,100 shares over the past 30 days. Haemonetics has a market cap of $1.7 billion and is part of the health care sector and health services industry. Shares are up 5.5% year to date as of the close of trading on Tuesday. Haemonetics Corporation, a healthcare company, provides blood management solutions to plasma and blood collectors, blood banks, hospitals and hospital service providers, and health organizations in the United States and internationally. The company has a P/E ratio of 26.8, equal to the average health services industry P/E ratio and above the S&P 500 P/E ratio of 16.3.
- Practice your HAE trading strategies and win cash in our stock game.